Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

TaiMed Biologics Inc. (4147) Financial Statements

TaiMed Biologics Inc. Financial Overview

TaiMed Biologics Inc.'s market cap is currently NT$16.47B. The company's EPS TTM is NT$-0.51; its P/E ratio is -103.67; TaiMed Biologics Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 611.35MNT$ 610.16MNT$ 491.78MNT$ 563.01MNT$ 413.44M
Gross ProfitNT$ 259.45MNT$ 211.22MNT$ 225.23MNT$ 215.71MNT$ 83.95M
Operating IncomeNT$ -194.65MNT$ -252.27MNT$ -166.23MNT$ -259.19MNT$ -463.49M
EBITDANT$ -41.66MNT$ -35.57MNT$ -24.61MNT$ -102.74MNT$ -306.83M
Net IncomeNT$ -167.78MNT$ -201.83MNT$ -194.81MNT$ -279.39MNT$ -478.38M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.77BNT$ 1.65BNT$ 649.13MNT$ 645.40MNT$ 960.89M
Total AssetsNT$ 4.81BNT$ 5.00BNT$ 3.89BNT$ 4.10BNT$ 4.61B
Total DebtNT$ 493.12MNT$ 522.63MNT$ 750.86MNT$ 766.14MNT$ 567.32M
Net DebtNT$ -405.26MNT$ -57.60MNT$ 499.85MNT$ 492.03MNT$ 15.71M
Total LiabilitiesNT$ 953.05MNT$ 976.34MNT$ 1.33BNT$ 1.39BNT$ 1.67B
Stockholders' EquityNT$ 3.86BNT$ 4.02BNT$ 2.57BNT$ 2.71BNT$ 2.94B
Cash Flow
Free Cash FlowNT$ 168.47MNT$ -398.90MNT$ -31.75MNT$ -609.97MNT$ -224.84M
Operating Cash FlowNT$ 191.14MNT$ -379.55MNT$ -25.60MNT$ -605.21MNT$ -211.28M
Investing Cash FlowNT$ 154.02MNT$ -714.84MNT$ -16.45MNT$ 106.11MNT$ 190.92M
Financing Cash FlowNT$ -21.64MNT$ 1.41BNT$ 19.23MNT$ 208.38MNT$ 2.79M

Currency in TWD

TaiMed Biologics Inc. Earnings and Revenue History

-800M0800M1.6B-7500 %-5000 %-2500 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

TaiMed Biologics Inc. Liabilities to Assets

02B4B6B0 %15 %30 %45 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

TaiMed Biologics Inc. Cash Flow

-1B-500M0500M1B1.5B2B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

TaiMed Biologics Inc. Forecast EPS vs Actual EPS

-0.4-0.3-0.2-0.100.10.2Q2 25Q3 25Q4 25Q1 26Q3 26EPS EstimateBeatMiss
Earnings >